ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 15 filers reported holding ADIAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22 | -37.1% | 107,100 | +6.1% | 0.00% | – |
| Q1 2023 | $35 | -35.2% | 100,900 | -59.9% | 0.00% | – |
| Q4 2022 | $54 | -99.9% | 251,886 | +74.6% | 0.00% | – |
| Q3 2022 | $50,000 | -78.0% | 144,230 | -14.9% | 0.00% | – |
| Q2 2022 | $227,000 | +467.5% | 169,400 | +748.8% | 0.00% | – |
| Q1 2022 | $40,000 | -76.2% | 19,958 | -79.8% | 0.00% | – |
| Q4 2020 | $168,000 | -18.8% | 98,900 | +6.5% | 0.00% | – |
| Q3 2020 | $207,000 | +256.9% | 92,907 | +121.2% | 0.00% | – |
| Q2 2020 | $58,000 | – | 42,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 293,908 | $494,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 315 | $1,000 | 0.00% |
| UBS Group AG | 1,692 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 650 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 77,985 | $131,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,900 | $3,000 | 0.00% |
| MORGAN STANLEY | 535 | $1,000 | 0.00% |
| BROWN ADVISORY INC | 26,040 | $44,000 | 0.00% |
| BlackRock Inc. | 205,684 | $346,000 | 0.00% |